Connect with us

Business

Hundreds of Hull families to get school uniform money

Published

on

Hundreds of Hull families to get school uniform money


More than 1,000 students will get extra help with school uniform costs, Hull City Council has said.

Next month, Year 7 pupils in Hull who receive free school meals will be given a £50 uniform voucher – £10 more than in previous years.

The money, from the government’s Household Support Fund, will be distributed to families before the October half term.

Council leader Mike Ross said: “We are absolutely aware that we are still in a cost of living crisis, so we hope these increased grants can help make a difference.”

Ross added: “We know that £50 won’t cover every item of uniform, which is why we’ve called on the government to provide additional support to local authorities like Hull to be able to provide more help for children from low-income families.

“Having been asked to look at the level of funding for school uniforms by full council, I know it was the right move to increase the amount available for those in need.”



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Jaguar Land Rover suppliers ‘face bankruptcy’ due to hack crisis

Published

on

Jaguar Land Rover suppliers ‘face bankruptcy’ due to hack crisis


The past two weeks have been dreadful for Jaguar Land Rover (JLR), and the crisis at the car maker shows no sign of coming to an end.

A cyber attack, which first came to light on 1 September, forced the manufacturer to shut down its computer systems and close production lines worldwide.

Its factories in Solihull, Halewood, and Wolverhampton are expected to remain idle until at least Wednesday, as the company continues to assess the damage.

JLR is thought to have lost at least £50m so far as a result of the stoppage. But experts say the most serious damage is being done to its network of suppliers, many of whom are small and medium sized businesses.

The government is now facing calls for a furlough scheme to be set up, to prevent widespread job losses.

David Bailey, professor of business economics at Aston University, told the BBC: “There’s anywhere up to a quarter of a million people in the supply chain for Jaguar Land Rover.

“So if there’s a knock-on effect from this closure, we could see companies going under and jobs being lost”.

Under normal circumstances, JLR would expect to build more than 1,000 vehicles a day, many of them at its UK plants in Solihull and Halewood. Engines are assembled at its Wolverhampton site. The company also has large car factories in China and Slovakia, as well as a smaller facility in India.

JLR said it closed down its IT networks deliberately in order to protect them from damage. However, because its production and parts supply systems are heavily automated, this meant cars simply could not be built.

Sales were also heavily disrupted, though workarounds have since been put in place to allow dealerships to operate.

Initially, the carmaker seemed relatively confident the issue could be resolved quickly.

Nearly two weeks on, it has become abundantly clear that restarting its computer systems has been a far from simple process. It has already admitted that some data may have been seen or stolen, and it has been working with the National Cyber Security Centre to investigate the incident.

Experts say the cost to JLR itself is likely to be between £5m and £10m per day, meaning it has already lost between £50m and £100m. However, the company made a pre-tax profit of £2.5bn in the year to the end of March, which implies it has the financial muscle to weather a crisis that lasts weeks rather than months.

JLR sits at the top of a pyramid of suppliers, many of whom are highly dependent on the carmaker because it is their main customer.

They include a large number of small and medium-sized firms, which do not have the resources to cope with an extended interruption to their business.

“Some of them will go bust. I would not be at all surprised to see bankruptcies,” says Andy Palmer, a one-time senior executive at Nissan and former boss of Aston Martin.

He believes suppliers will have begun cutting their headcount dramatically in order to keep costs down.

Mr Palmer says: “You hold back in the first week or so of a shutdown. You bear those losses.

“But then, you go into the second week, more information becomes available – then you cut hard. So layoffs are either already happening, or are being planned.”

A boss at one smaller JLR supplier, who preferred not to be named, confirmed his firm had already laid off 40 people, nearly half of its workforce.

Meanwhile, other companies are continuing to tell their employees to remain at home with the hours they are not working to be “banked”, to be offset against holidays or overtime at a later date.

There seems little expectation of a swift return to work.

One employee at a major supplier based in the West Midlands told the BBC they were not expecting to be back on the shop floor until 29 September. Hundreds of staff, they say, had been told to remain at home.

When automotive firms cut back, temporary workers brought in to cover busy periods are usually the first to go.

There is generally a reluctance to get rid of permanent staff, as they often have skills that are difficult to replace. But if cashflow dries up, they may have little choice.

Labour MP Liam Byrne, who chairs the Commons Business and Trade Committee, says this means government help is needed.

“What began in some online systems is now rippling through the supply chain, threatening a cashflow crunch that could turn a short-term shock into long-term harm”, he says.

“We cannot afford to see a cornerstone of our advanced manufacturing base weakened by events beyond its control”.

The trade union Unite has called for a furlough system to be set up to help automotive suppliers. This would involve the government subsidising workers’ pay packets while they are unable to do their jobs, taking the burden off their employers.

“Thousands of these workers in JLR’s supply chain now find their jobs are under an immediate threat because of the cyber attack,” says Unite general secretary, Sharon Graham.

“Ministers need to act fast and introduce a furlough scheme to ensure that vital jobs and skills are not lost while JLR and its supply chain get back on track.”

Business and Trade Minister Chris Bryant said: “We recognise the significant impact this incident has had on JLR and their suppliers, and I know this is a worrying time for those affected.

“I met with the chief executive of JLR yesterday to discuss the impact of the incident. We are also in daily contact with the company and our cyber experts about resolving this issue.”



Source link

Continue Reading

Business

AstraZeneca pauses £200m Cambridge investment

Published

on

AstraZeneca pauses £200m Cambridge investment


Mitchell LabiakBusiness reporter and

Simon JackBusiness editor

Getty Images Pharmaceutical company Astrazeneca's logo on the side of an office building with dark opaque windows. There is a grey sky behind the building.Getty Images

AstraZeneca has paused plans to invest £200m at a Cambridge research site in a fresh blow to the UK pharmaceutical industry.

The project, which was set to create 1,000 jobs, was announced in March 2024 by the previous government alongside another project in Liverpool, which was shelved in January.

Friday’s announcement comes after US pharmaceutical giant Merck scrapped a £1bn UK expansion, blaming a lack of government investment, and as President Donald Trump pressures pharmaceutical firms to invest more in the US.

An AstraZeneca spokesperson said: “We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused.”

Over the last 10 years, UK spending on medicines has fallen from 15% of the NHS budget to 9%, while the rest of the developed world spends between 14% and 20%.

Meanwhile, pharmaceutical companies have been looking to invest in the US following Trump’s threats of sky-high tariffs on drug imports.

In July, AstraZeneca said it would invest $50bn (£36.9bn) in the US on “medicines manufacturing and R&D [research and development]”.

Earlier this week Merck, which had already begun construction on a site in London’s King’s Cross which was due to be completed by 2027, said it no longer planned to occupy it.

The multi-national business, known as MSD in Europe, said it would move its life sciences research to the US and cut UK jobs, blaming successive governments for undervaluing innovative medicines.

Getty Images A close up of Pascal Soriot, chief executive officer of AstraZeneca Plc, speaking into a microphone during a signing ceremony event in Washington, DC in July where he was announcing the firm's $50bn investment in the US. He is wearing a dark suit and a white shirt and a US flag is in soft focus behind him.Getty Images

AstraZeneca boss Pascal Soriot announced the firm’s $50bn investment in the US in July

AstraZeneca’s announcement on Friday means none of the £650m UK investment trumpeted by the last government will currently happen.

The paused Cambridge project would have been an expansion of its existing Discovery Centre, which already hosts 2,300 researchers and scientists.

The stoppage comes after it scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside in January, blaming a reduction in government support.

It said at the time that after “protracted” talks, a number of factors influenced the move, including “the timing and reduction of the final offer compared to the previous government’s proposal”.

Successive UK governments have pointed to life sciences as one of its most successful industries.

Former chancellor Jeremy Hunt said the sector was “crucial for the country’s health, wealth and resilience” while Chancellor Rachel Reeves said AstraZeneca was one of the UK’s “great companies” days before it scrapped its Liverpool expansion.



Source link

Continue Reading

Business

Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots

Published

on

Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots


Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

Dado Ruvic | Reuters

Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. 

The report from the Washington Post said officials plan to include the claim in a presentation next week to a key vaccine panel that advises the Centers for Disease Control and Prevention.That committee plays a critical role in determining vaccine access, as it reviews immunization data and makes recommendations on who is eligible for shots and whether insurers should cover them, among other duties.

But the presentation to that panel is not final, the Post reported.

“FDA and CDC staff routinely analyze VAERS and other safety monitoring data, and those reviews are being shared publicly through the established ACIP process,” a spokesperson for the Department of Health and Human Services said in a statement, referring to the panel, the Advisory Committee on Immunization Practices.

“Until that is shared publicly, any this should be considered pure speculation,” the spokesperson added.

Pfizer’s stock fell more than 3% on Friday, while shares of Moderna dropped more than 7%. Novavax, which creates protein-based Covid shots, slid more than 4%.

The report comes as Health and Human Services Secretary Robert F. Kennedy Jr. moves to change vaccine policy in the U.S. He has dropped Covid shot recommendations for healthy kids and pregnant women and set new limits on the approval of new jabs against the virus.

In a statement, Moderna said the safety of its vaccine is “rigorously monitored” by the company, the FDA and regulators in more than 90 countries. Systems across the U.S., Australia, Canada and Europe have not identified “any new or undisclosed safety concerns in children or in pregnant women,” Moderna added.

Pfizer did not immediately respond to a request for comment.

Numerous studies have demonstrated that shots using mRNA technology, including Covid vaccines from Pfizer and Moderna, are safe and effective, and serious side effects have happened in extremely rare cases.

Researchers have noted an elevated but rare risk of myocarditis, or inflamed heart muscle, in young men in particular. But there is no evidence that the vaccines in use now cause any other major safety risks, including pediatric deaths. Global surveillance data also continue to generally show that the benefits of Covid vaccination outweigh the risks in pediatric populations.

The Washington Post said the claim appears to be based on information submitted to the federal Vaccine Adverse Event Reporting System, which monitors the safety of shots approved or authorized by the Food and Drug Administration. The system contains unverified reports of side effects, including from patients, doctors and pharmacists.

Only scientists and public health officials can determine, after thorough investigation, whether a vaccine caused or contributed to a side effect submitted to the system, according to the CDC website.

Last week, FDA Commissioner Marty Makary told CNN the agency is conducting an “intense investigation” into whether Covid shots have caused deaths in children. He did not share specific data linking pediatric deaths to the vaccine, but pointed to self-reported incidents in the safety system database. 

The FDA plans to release a report in the coming weeks, Makary added.

“We do know at the FDA, because we’ve been looking into the [vaccine safety] database of self reports, that there have been children who have died from the Covid vaccine,” Makary told CNN.

During a Senate hearing last week, Kennedy said he supports a statement made by a newly appointed member of a key government vaccine panel that mRNA vaccines pose a dangerous risk to people.



Source link

Continue Reading

Trending